As befits a fast-paced, dynamic industry, the life sciences regulatory landscape is perpetually in flux. For the past 11 years, IQVIA has rigorously documented best practices in how pharmaceutical companies, medical device manufacturers and other industry firms collect and report data pertaining to HCP engagements.
The 2020 survey includes the perspectives of nearly 50 stakeholders at biotech, pharmaceutical and medical device manufacturers. The collection and analysis of their responses achieves the most comprehensive assessment available today of insights in compliance, reporting and relationship management controls and protocols. The granular level of insight into this data captures the trend lines across mission-critical activities within the promotional education and engagement spectrum.